Literature DB >> 23928328

Late diagnosis of an outbreak of leanness-enhancing agent-related food poisoning.

Ming-Ling Wu1, Jou-Fang Deng, Yi Chen, Wei-Lan Chu, Dong-Zong Hung, Chen-Chang Yang.   

Abstract

INTRODUCTION: Ractopamine is a leanness-enhancing agent approved in the United States and 26 other countries to reduce body fat content, increase muscle mass, and improve growth rate of certain food-producing animals. Other β-agonists with stronger pharmacologic effects, especially clenbuterol, had been illegally used as leanness-enhancing agents in the United States, China, and the European Union, and foodborne poisonings related to clenbuterol residue in meat or liver were rarely reported in the European Union and China. We describe an unusual outbreak of leanness-enhancing agent-related food poisoning in Taiwan and its associated diagnostic challenge. REPORT OF THE OUTBREAK: Twelve patients presented to the emergency department of a regional hospital after having dinner together. Their clinical manifestations included nausea, vomiting, palpitation, facial flush, trunk or limb numbness, tremor, headache, weakness, chill, and dyspnea. Laboratory workup revealed the presence of hypokalemia, leukocytosis, and hyperglycemia. Poisoning attributable to β-agonists was suspected; however, the diagnosis of leanness-enhancing agent poisoning was delayed because there was no leftover meat for analysis and because the veterinary medicine was illegal in Taiwan. Clenbuterol and salbutamol were eventually detected in 10 patients' urine sample by using liquid chromatography-tandem mass spectrometry, and the concentrations ranged from 54 to 806 μg/L and from 0 to 4052 μg/L, respectively.
CONCLUSION: β-Agonist leanness-enhancing agent-related food poisonings are rarely encountered, especially in those countries where relevant veterinary medicines are banned, and may thus pose diagnostic challenge to both emergency physicians and clinical toxicologists.
© 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23928328     DOI: 10.1016/j.ajem.2013.07.001

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  Urinary Excretion of the β-Adrenergic Feed Additives Ractopamine and Zilpaterol in Breast and Lung Cancer Patients.

Authors:  Ting-Yuan David Cheng; Weilin L Shelver; Chi-Chen Hong; Susan E McCann; Warren Davis; Yali Zhang; Christine B Ambrosone; David J Smith
Journal:  J Agric Food Chem       Date:  2016-09-27       Impact factor: 5.279

2.  Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1.

Authors:  Xuehong Liu; David K Grandy; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2014-05-05       Impact factor: 4.030

3.  Excretion and Residual Concentration Correlations of Salbutamol Between Edible Tissues and Living Samples in Pigs and Goats.

Authors:  Lei Sun; Minjuan Zhu; Jingfei Shi; Kun Mi; Wenjing Ma; Xiangyue Xu; Hanyu Wang; Yuanhu Pan; Yanfei Tao; Zhenli Liu; Lingli Huang
Journal:  Front Pharmacol       Date:  2021-11-25       Impact factor: 5.810

4.  Simultaneous detection of forbidden chemical residues in milk using dual-label time-resolved reverse competitive chemiluminescent immunoassay based on amine group functionalized surface.

Authors:  Dongdong Zhang; Xiaoqi Tao; Haiyang Jiang; Kai Wen; Jianzhong Shen; Xingyuan Cao
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

Review 5.  Current Advances in Immunoassays for the Detection of β2-Agonists.

Authors:  Shuyu Ouyang; Shuting Yu; Yingying Le
Journal:  Foods       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.